Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

Abstract Background Anti-TNF treatment may be useful for the treatment of patients with refractory juvenile dermatomyositis (JDM). The aim of this study was to describe the use of infliximab and adalimumab therapy in juvenile dermatomyositis as an adjunctive treatment. Methods Sixty children recruit...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Raquel Campanilho-Marques, Claire T. Deakin, Stefania Simou, Charalampia Papadopoulou, Lucy R. Wedderburn, Clarissa A. Pilkington, for the Juvenile Dermatomyositis Research Group (JDRG)
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-04-01
coleção:	Arthritis Research & Therapy
Assuntos:	Infliximab Adalimumab Juvenile dermatomyositis Biologic therapy P rheumatology
Acesso em linha:	http://link.springer.com/article/10.1186/s13075-020-02164-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!